Related Experiment Videos
Almotriptan: a balanced approach to migraine
1Head Clinic, Western General Hospital, Edinburgh EH4 2XU.
Hospital Medicine (London, England : 1998)
|March 10, 2001
Summary
Migraine treatment with 4HT(1B/1D) agonists, known as triptans, has faced challenges. Almotriptan presents potential advantages over older migraine medications.
Area of Science:
- Neurology
- Pharmacology
Background:
- 4HT(1B/1D) agonists (triptans) are effective for acute migraine treatment.
- Triptan use in the UK is limited by concerns regarding efficacy, recurrence, adverse events, and cost.
Purpose of the Study:
- To evaluate almotriptan as a potential alternative for acute migraine treatment.
- To highlight the advantages of almotriptan over existing triptan agents.
Main Methods:
- Review of clinical data on almotriptan efficacy and safety.
- Comparison of almotriptan with previously available triptans.
Main Results:
- Almotriptan demonstrates advantages over earlier triptan medications.
- Addresses some limitations associated with current migraine treatments.
Conclusions:
- Almotriptan offers a promising option for acute migraine management.
- Further research may validate its improved profile in clinical practice.